Clinical Trial Update: An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects [Phase 4]

View source ↗

Summary

Phase 4 exploratory trial comparing repeat dosing of albiglutide to exenatide on gastric myoelectrical activity and gastric emptying in adults with type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Albiglutide (albiglutide)
• EXENATIDE (EXENATIDE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: TERMINATED | Results posted: 2018-05-23